Toggle light / dark theme

Trillo directed the Sora-powered video for the new single “The Hardest Part” by indie chillwave artist Washed Out (Ernest Weatherly Greene Jr.).

The video is 4 minutes long and has been created in a unique way. It is a long series of fast zooms through different scenes that are connected to feel like one continuous zoom.

While giving details about the video, Trillo posted on X that he had the idea for this video for a long time but couldn’t make it happen until now.

We’re not even halfway through 2024, but it’s already an interesting year in the world of gadgets. Though tech giants usually release the typical assortment of new phones, smartwatches, laptops and tablets on an annual (or semiannual) basis, this year saw the debut of a few firsts.

Apple and Samsung, the world’s two largest smartphone makers, both expanded into new categories, with the iPhone maker releasing its Vision Pro mixed reality headset and the Korean tech giant announcing the Galaxy Ring, a wellness tracker meant to be worn around the finger. Startups Rabbit and Humane AI also generated plenty of hype with their AI-fueled gadgets, both of which require you to dictate commands to portable AI agents rather than swiping on screens.

So what do the Apple Vision Pro, Samsung Galaxy Ring, Rabbit R1 and Humane AI Pin have in common? Not much it seems, at least on the surface. But all these gadgets share one common goal: to change our relationship with screens.

The following is a summary of “Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control,” published in the April 2024 issue of Urology by Zhu et al.

In this study, researchers address the notable gap in high-level evidence comparing oncologic endpoints for partial gland ablation, where most existing series rely on prostate-specific antigen (PSA) rather than biopsy endpoints. The objective was to conduct a comprehensive comparison of oncologic outcomes between partial gland cryoablation (PGC) and radical prostatectomy (RP) for the management of prostate cancer.

Through a retrospective, single-center analysis, investigators examined a cohort of subjects treated with either PGC (n = 98) or RP (n = 536) as primary treatment for intermediate-risk (Gleason grade group [GG] 2–3) prostate cancer between January 2017 and December 2022. Key oncologic endpoints included surveillance biopsies per protocol after PGC and serial PSA testing after RP. The primary outcome of interest was treatment failure, which is defined as the necessity for salvage treatment or metastatic disease development. The study group conducted treatment failure and survival analyses using Cox proportional-hazard regression and Kaplan-Meier survival curves. After carefully applying inclusion/exclusion criteria, they compared the PGC (n = 75) and RP (n = 298) groups.